quinoxalines has been researched along with 11-cis-retinal in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bock, MG; Chang, R; Chen, TB; Freidinger, RM; Ha, SN; Harrell, CM; Hess, FJ; Hey, PJ; Markowitz, MK; Murphy, KL; Ransom, RW; Su, DS | 1 |
Bamberg, E; Boyden, ES; Deisseroth, K; Nagel, G; Zhang, F | 1 |
Awatramani, GB; Balya, D; Busskamp, V; Cepko, CL; Kim, DS; Lagali, PS; Münch, TA; Roska, B | 1 |
Catarzi, D; Ciampi, O; Colotta, V; Filacchioni, G; Lenzi, O; Martini, C; Morizzo, E; Moro, S; Pedata, F; Pugliese, AM; Traini, C; Trincavelli, L; Varano, F | 1 |
Crowley, JJ; Fioravante, D; Regehr, WG | 1 |
Cetin, AH; Charlet, A; Eliava, M; Grinevich, V; Hoffmann, LC; Khrulev, S; Knobloch, HS; Osten, P; Schwarz, MK; Seeburg, PH; Stoop, R | 1 |
Bosking, WH; Elyada, YM; Fitzpatrick, D; Huang, X; Walker, T | 1 |
7 other study(ies) available for quinoxalines and 11-cis-retinal
Article | Year |
---|---|
Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1.
Topics: Amino Acid Sequence; Binding Sites; Humans; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Binding; Protein Structure, Secondary; Quinoxalines; Receptor, Bradykinin B1; Rhodopsin; Sequence Alignment; Structural Homology, Protein | 2005 |
Millisecond-timescale, genetically targeted optical control of neural activity.
Topics: Action Potentials; Algal Proteins; Animals; Animals, Newborn; Cells, Cultured; Dose-Response Relationship, Radiation; Electric Stimulation; Electrophysiology; Excitatory Amino Acid Antagonists; GABA Antagonists; Green Fluorescent Proteins; Hippocampus; Ion Channel Gating; Ion Channels; Neural Inhibition; Neurons; Optics and Photonics; Photobiology; Pyridazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Reaction Time; Reproducibility of Results; Rhodopsin; Synaptic Transmission; Time Factors; Transfection | 2005 |
Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Electroporation; Evoked Potentials, Visual; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Light; Luminescent Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Patch-Clamp Techniques; Photic Stimulation; Piperazines; Quinoxalines; Retinal Bipolar Cells; Retinal Degeneration; Retinal Ganglion Cells; Rhodopsin; Time Factors; Vision, Ocular; Visual Pathways | 2008 |
Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists.
Topics: Adenosine A3 Receptor Antagonists; Animals; Binding, Competitive; Brain Ischemia; Cattle; Cell Membrane; Cerebral Cortex; Disease Models, Animal; Humans; Hydrogen Bonding; Ligands; Models, Molecular; Protein Binding; Quinoxalines; Rats; Receptor, Adenosine A3; Rhodopsin; Structural Homology, Protein; Structure-Activity Relationship; Triazoles; Xanthines | 2008 |
Dynamics of fast and slow inhibition from cerebellar golgi cells allow flexible control of synaptic integration.
Topics: Action Potentials; Animals; Animals, Newborn; Biophysics; Cell Line, Transformed; Cerebellum; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Antagonists; Humans; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Neural Inhibition; Neurons; Nonlinear Dynamics; Patch-Clamp Techniques; Phosphinic Acids; Photic Stimulation; Piperazines; Propanolamines; Quinoxalines; Rats; Rats, Sprague-Dawley; Rhodopsin; Synapses; Time Factors; Transfection | 2009 |
Evoked axonal oxytocin release in the central amygdala attenuates fear response.
Topics: Action Potentials; Amygdala; Analysis of Variance; Animals; Axons; Behavior, Animal; Conditioning, Psychological; Excitatory Amino Acid Antagonists; Fear; Female; Fiber Optic Technology; GABA Antagonists; Gene Expression Regulation; Genetic Vectors; Green Fluorescent Proteins; Hypothalamus; In Vitro Techniques; Inhibition, Psychological; Lactation; Light; Microscopy, Electron, Transmission; Models, Biological; Neurons; Oxytocin; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Picrotoxin; Prosencephalon; Quinoxalines; Rats; Rats, Wistar; Rhodopsin; Time Factors; Vasotocin; Vesicular Glutamate Transport Protein 2 | 2012 |
Optogenetic assessment of horizontal interactions in primary visual cortex.
Topics: Action Potentials; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Excitatory Amino Acid Antagonists; Female; Luminescent Proteins; Male; Microscopy, Confocal; Neurons; Optogenetics; Orientation; Photic Stimulation; Quinoxalines; Rhodopsin; Synapsins; Tupaiidae; Valine; Visual Cortex; Visual Pathways | 2014 |